| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2002 | US6387935 Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals |
| 05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 05/14/2002 | US6387929 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 05/14/2002 | US6387927 Water solubility |
| 05/14/2002 | US6387926 Inhibitors of farnesyl protein transferase |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/14/2002 | US6387924 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 05/14/2002 | US6387920 Isoxazole compounds; for treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, alzheimer's disease |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387917 Nasal administering |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387914 Providing sedative-hypnotic treatment by administering barbiturate derivative compound |
| 05/14/2002 | US6387913 Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists |
| 05/14/2002 | US6387912 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia |
| 05/14/2002 | US6387911 Pyrazinone thrombin inhibitors |
| 05/14/2002 | US6387910 Lomerizine |
| 05/14/2002 | US6387907 Drug mixture; sleep disorders |
| 05/14/2002 | US6387906 Dermatophytes |
| 05/14/2002 | US6387904 Method of treating glaucoma and ischemic retinopathy |
| 05/14/2002 | US6387900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
| 05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387897 Preferentially substituted calcium channel blockers |
| 05/14/2002 | US6387896 Bicyclic oxazolidinones as antibacterial agents |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387894 Use of CRF antagonists and renin-angiotensin system inhibitors |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/14/2002 | US6387890 Compositions and methods for inhibiting arginase activity |
| 05/14/2002 | US6387889 Reducing ocular tension |
| 05/14/2002 | US6387886 Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic |
| 05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
| 05/14/2002 | US6387880 Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L-α-aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts |
| 05/14/2002 | US6387876 Covalent polar lipid-conjugates with biologically active compounds for use in salves |
| 05/14/2002 | US6387701 Method of identifying tumor antigens that elicit a T-cell response |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387629 Use of cathepsin S in the diagnosis and treatment of endometriosis |
| 05/14/2002 | US6387617 Proto-nucleozyme having catalytic activity in presence of non-nucleic cofactor which chemically interacts to provide missing component; viricides; anticarcinogenic agents |
| 05/14/2002 | US6387612 Method of preparing a terminally heat sterilized plasma-like solution |
| 05/14/2002 | US6387417 Hinokitol, a metal complex or salt |
| 05/14/2002 | US6387411 Concurrent melting |
| 05/14/2002 | US6387410 Mixture containing nsaid, prostaglandin and one or more excipients |
| 05/14/2002 | US6387407 Topical drug preparations |
| 05/14/2002 | US6387403 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 05/14/2002 | US6387400 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387392 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva |
| 05/14/2002 | US6387390 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 05/14/2002 | US6387389 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use |
| 05/14/2002 | US6387383 Topical low-viscosity gel composition |
| 05/14/2002 | US6387382 Water-proof, respirable, skin barrier composition |
| 05/14/2002 | US6387379 Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387376 Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387370 Reducing oxysterol buildup in the blood and normalizing cholesterol and blood pressure; phytochemicals with antioxidant properties found in fruits and vegetables, including polyphenols |
| 05/14/2002 | US6387365 Alpha interferon and ribavirin where the amount of alpha interferon is less than 3 million iu weekly, qod or daily; alpha interferon is interferon alpha2; reduction of side effects |
| 05/14/2002 | US6387364 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/14/2002 | US6387363 Absorbable sutures; synthetic lactic acid and glycolic acid copolylactone; each successive monomer can be specifically specified; cell-free translation system; synthetic messenger ribonucleic acid (mrna) as a template |
| 05/14/2002 | US6387361 Eating acarbose with meals with food containing carbohydrates |
| 05/14/2002 | US6387358 Antiperspirant compositions |
| 05/14/2002 | US6387258 Method of purifying statins from a fermentation broth |
| 05/14/2002 | US6386145 Process for curing diseases in cultured fish |
| 05/14/2002 | CA2361160A1 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
| 05/14/2002 | CA2354832C Chlorella preparations exhibiting immunomodulating properties |
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/14/2002 | CA2263905C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 05/14/2002 | CA2260898C Phosphinate based inhibitors of matrix metalloproteases |
| 05/14/2002 | CA2255665C Creatine pyruvates and method for their production |
| 05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 05/14/2002 | CA2249666C Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 05/14/2002 | CA2247105C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic di seases |
| 05/14/2002 | CA2234235C Gel formulations containing growth factors |
| 05/14/2002 | CA2214829C Methods and compositions for in-vivo detection of oral cancers and precancerous conditions |
| 05/14/2002 | CA2202030C Method for reducing unwanted cellular adhesions |
| 05/14/2002 | CA2179540C Accelerated release composition containing bromocriptine |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2150162C New n-pyridyl carboxamides and derivatives thereof, preparation processes thereof and pharmaceutical compositions containing thereof |
| 05/14/2002 | CA2129287C Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension |
| 05/14/2002 | CA2105071C Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| 05/14/2002 | CA2105067C Indan derivative and thromboxane antagonist containing the same |
| 05/14/2002 | CA2089657C Topical treatment of blepharitis |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2075876C Arylethylamines derivatives, process for their preparation and pharmaceutical compositions holding same |
| 05/14/2002 | CA2061196C Acetylsalicyloyl l-carnitine and process for its preparation |
| 05/14/2002 | CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes |
| 05/14/2002 | CA2033418C Pharmaceutical preparation for oral administration in fluid form |
| 05/14/2002 | CA2023899C Anti-sense oligonucleotide sequence, anti-rna messenger of tnf alpha, process for its preparation, use as medicament and pharmaceutical composition |
| 05/14/2002 | CA2010542C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | WO2002036734A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 05/10/2002 | WO2002036605A2 Estrone-derivatives having cytoprotective activity |
| 05/10/2002 | WO2002036602A1 Novel pyrazole derivatives and diabetes remedies containing the same |
| 05/10/2002 | WO2002036601A2 Phase transfer catalyzed glycosidation of an indolocarbazole |
| 05/10/2002 | WO2002036599A1 Thieno[2,3-c]isoquinolines for use as inhibitors of parp |